Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant modified human growth hormone

EU orphan designation number: EU/3/12/1087   
Active ingredient: Recombinant modified human growth hormone
Indication: Treatment of growth hormone deficiency
Sponsor: Richardson Associates Regulatory Affairs Ltd
22 Northumberland Road, Ballsbridge, Dublin 4 D04 ED73, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2013 Orphan designation EMA/OD/133/12 (2013)476 of 24/01/2013
19/12/2018 Transfer of orphan designation EMA/OD/0000002652 (2018)9014 of 14/12/2018